GENE ONLINE|News &
Opinion
Blog

Degrader-Antibody Conjugate
Trials & Approvals DACDegrader-Antibody ConjugatePROTACADCAntibody-Drug ConjugateBTK DegraderAntibody Neodegrader Conjugate
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
DACDegrader-Antibody ConjugatePROTAC
Degrader-Antibody Conjugates (DACs): Targeted Protein Degradation for Therapeutics
2024-02-19
LATEST
Kailera Therapeutics Launches Commercial Strategy Following $625 Million IPO
2026-06-08
Cohen & Company Securities Opens New Office in Charlotte
2026-06-08
The Crème School Opens First California Preschool Campus in Irvine
2026-06-08
ReconAfrica Begins Production Testing at Kavango West 1X Well in Namibia
2026-06-08
HUHUTECH Launches HB-800 Vacuum Furnace for Semiconductor Production
2026-06-08
Enovis Launches Spinamic Hybrid Scoliosis Brace for Pediatric Patients
2026-06-08
Winners Inc. to Host Live Prediction Market During NBA Finals Game 3 at Madison Square Garden
2026-06-08
READ MORE
EVENT
20260622
BIO International Convention (Global Biotech Showcase)
Boston, Massachusetts
20260625
Medical Taiwan 2026 (Devices, Diagnostics, Digital & Smart Health)
Taipei, Taiwan
20260625
ASCO Breakthrough 2026 (Next-Gen Oncology Innovation)
Singapore
20260708
ISSCR (Regenerative Medicine &Cell Therapy)
Montreal, Canada
20260715
BIO Asia-Taiwan 2026 (APAC Biotech & Investment)
Taipei, Taiwan
20260807
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
SEE MORE
Scroll to Top